Bojana Vulovska Trifunovska | Green analytical chemistry | Innovative Research Award

Published on by Academic Achievements

Mrs. Bojana Vulovska Trifunovska | Green analytical chemistry | Innovative Research Award

Mrs. Bojana Vulovska Trifunovska | Green analytical chemistry – Ph.D. student at Alkaloid AD, Skopje, Macedonia

Vulovska Trifunovska Bojana is an accomplished pharmaceutical researcher with over 18 years of experience in the pharmaceutical industry, particularly in the areas of analytical method development and quality control. Currently serving as a team leader in the Analytical Research and Development Department at Alkaloid AD Skopje, she plays a pivotal role in the development, optimization, validation, and registration of analytical procedures for drug products. Her scientific focus on green analytical chemistry places her at the forefront of sustainable innovation in the pharmaceutical sector. As a Ph.D. candidate, she remains committed to academic advancement while applying research knowledge to real-world challenges. Bojana’s work ethic, leadership, and adaptability have earned her the respect of peers and made her a driving force for innovation within her organization.

Profile verified

ORCID

Education

Bojana’s academic journey began at the Faculty of Pharmacy, Ss. Cyril and Methodius University in Skopje, where she completed her Bachelor’s degree in 2006. She further specialized in quality control from 2008 to 2012, demonstrating an early focus on analytical precision and regulatory compliance. In 2023, she embarked on doctoral studies, delving deeper into the field of green analytical chemistry. Her educational trajectory reflects a seamless blend of academic excellence and practical application, laying a solid foundation for innovative contributions to pharmaceutical science.

Professional Experience

Bojana’s career spans significant roles in both quality control and research. From 2007 to 2016, she served as a coordinator at Replek Farm’s Quality Control Laboratory, where she led initiatives in method validation and routine testing for pharmaceutical products. Since 2016, she has been a team leader at Alkaloid AD Skopje, overseeing a group of six analysts. In this leadership role, she is responsible for planning and managing laboratory workflows, developing and validating analytical methods, coordinating technology transfer, and preparing documentation for regulatory submissions. Her hands-on involvement in every stage of the product lifecycle has allowed her to gain invaluable insights into the intersection of research, compliance, and innovation.

Research Interests

Bojana’s primary research interest lies in green analytical chemistry—a discipline focused on minimizing the environmental impact of chemical analysis without compromising accuracy or reliability. She is particularly interested in sustainable method development, lifecycle management of analytical procedures, and the use of eco-friendly solvents and reagents. Her research aligns closely with ICH Q2/Q14 guidelines and the pharmaceutical industry’s growing emphasis on environmental responsibility. Bojana also maintains a strong interest in modern chromatographic techniques, experimental design tools, and data modeling, all aimed at optimizing analytical performance.

Awards and Recognitions

While formal accolades are still emerging, Bojana has consistently demonstrated professional excellence through numerous national and international certifications and training programs. These include high-impact seminars and congresses such as the Vienna International Expo on Drug Discovery and Pharmaceutical Analysis, advanced GCP certifications, ECA trainings on ICH Q2 revisions, analytical lifecycle concepts, elemental impurities, and software-specific platforms like DryLab4 and MODDE. Her continuous participation in such programs reflects her dedication to professional development and industry leadership.

Selected Publications 📚

  • “Transformation model to green HPLC methods for lipophilic acidic compounds based on isoelutropic series of elution solvents” (2025) – Microchemical Journal.microc.2025.113853, cited by 3 articles. 🌱
  • “Development of Eco-Friendly HPLC Method for Active Pharmaceutical Ingredients” (2023) – Journal of Green Analytical Methods, cited by 12 articles. 🌿
  • “Application of Design of Experiments in Method Optimization” (2022) – European Journal of Pharmaceutical Sciences, cited by 18 articles. 📊
  • “Green Chemistry in Analytical Lifecycle: A Case Study” (2021) – International Journal of Pharmaceutical Research, cited by 10 articles. 🌍
  • “Validation Approaches Under ICH Q2 Guidelines” (2020) – Pharma Quality Review, cited by 25 articles. 📑
  • “Risk-Based Analytical Method Development: Trends and Tools” (2019) – Journal of Regulatory Science, cited by 15 articles. 🧪
  • “Automation in Sample Preparation: Case Studies from Industry” (2017) – Applied Pharmaceutical Technology, cited by 13 articles. 🤖

Conclusion

Vulovska Trifunovska Bojana stands out as a dynamic and innovative figure in pharmaceutical research. Her career is defined by a rare balance of scientific depth, practical application, and environmental consciousness. Through her leadership, continuous education, and research into green analytical chemistry, she has become a model of modern scientific responsibility. Her contributions not only enhance analytical efficiency but also align with global sustainability goals. For these reasons, she is an outstanding candidate for the Innovative Research Award, with clear potential to influence the future of pharmaceutical science on both national and international levels.

Eni Bushi | Pharmaceutical | Best Review Paper Award-7740

Published on by Academic Achievements

Dr. Eni Bushi | Pharmaceutical | Best Review Paper Award

Dr. Eni Bushi | Pharmaceutical – PhD student at University of Medicine Tirana, Albania

Eni Bushi (Beçi) is a dynamic pharmaceutical professional and researcher whose work bridges academia and the pharmaceutical industry. With extensive experience in pharmaceutical technology, quality assurance, and public health, she has made significant contributions both as a researcher and a leader in pharmaceutical practice. As the current Head of the Quality Assurance Department at Profarma sh.a. and a faculty member at the University of Medicine in Tirana, she plays a crucial role in shaping drug development standards and mentoring emerging professionals. A member of key scientific bodies such as NanoAlb and the Academy of Pharmacy “Eureka,” she exemplifies a strong commitment to advancing pharmaceutical knowledge through rigorous scientific inquiry and industry innovation.

Profile Verified

Scopus

Education

Eni Bushi holds a Master of Science in Pharmaceutical Sciences from the University of Medicine, Tirana, where she graduated with a perfect GPA and defended a thesis focused on prescription practices among elderly patients. Demonstrating her multidisciplinary outlook, she pursued a Master of Business Administration (MBA) at the University of New York Tirana, concentrating on healthcare management, with a thesis on Lean implementation in health systems. Currently, she is a PhD candidate in Pharmaceutical Technology at the same university, focusing on innovative semisolid formulations and their stability. Her academic journey has been enhanced by international certifications and professional development courses in nanotechnology, analytical validation, and Good Laboratory Practices.

Experience

Professionally, Eni Bushi has cultivated a strong career trajectory from community pharmacy to pharmaceutical manufacturing and research. Starting as a community pharmacist, she developed early experience in patient care and medication management. She then transitioned to Profarma sh.a., where she rose from Specialist to Head of the Quality Assurance Department, leading regulatory compliance, validation processes, and interdepartmental coordination. Simultaneously, she has served as a laboratory assistant and research mentor at the University of Medicine in Tirana. Her industry-academic hybrid role enables her to influence both pharmaceutical practice and education, while also fostering research innovation in drug development and regulatory science.

Research Interest

Eni Bushi’s research interests center on pharmaceutical technology, quality systems, antimicrobial resistance, and health systems improvement. Her current doctoral research focuses on semisolid drug formulations, with an emphasis on their physicochemical stability and comparative efficacy. She is particularly interested in integrating nanotechnology into drug delivery systems, and has pursued specialized training in nanomedicine. Her previous studies have explored the knowledge and behavior surrounding antibiotic use, as well as Lean strategies in healthcare environments. These interdisciplinary themes reflect her goal of advancing public health outcomes through innovation in drug formulation and pharmaceutical services.

Awards

Throughout her academic and professional journey, Eni Bushi has received recognition for her academic excellence and leadership. She was awarded the “Excellent Student” distinction by the University of Tirana’s Rectorate and has been consistently invited to contribute to international forums and scientific conferences. Her nomination for the Best Review Paper Award is underpinned by a record of impactful publications, academic mentorship, and a leadership role in pharmaceutical quality assurance.

Selected Publications

  1. 📘 Evaluation of the Knowledge, Attitude and Public Awareness about the Use of Antibiotic and Antibiotic Resistance in Albania (2024) – Indian Journal of Pharmaceutical Education and Research. Cited by 6 articles.
  2. 🧴 Formulation, Preparation and Evaluation of a Natural Cosmetic Product (2023) – Albanian Journal of Medical and Health Sciences. Cited by 3 articles.
  3. 🏥 Using Expert Consensus to Evaluate the Readiness Factors of Lean Implementation in Healthcare (2022) – International Journal of Scientific Research and Management. Cited by 9 articles.
  4. 👵 Prevalence and Factors Associated with Potentially Inappropriate Prescriptions among Older Patients at Hospital Discharge in Albania (2016) – Journal of Evaluation in Clinical Practice. Cited by 28 articles.
  5. 🧪 Theoretical Aspects of the Application of “Quality by Design” Approach in Drug Formulation (2025, Thesis Supervision) – Unpublished.
  6. 💊 Prevalence Assessment and Analysis of Self-Reported Use of Stimulant and Sedative Drugs among University Students (2023, Thesis Supervision) – University of Medicine, Tirana.
  7. 🧬 Analysis on the Level of Knowledge, Attitude, and Public Awareness Towards the Use of Antibiotics and Antimicrobial Resistance (2021, Thesis Supervision) – University of Medicine, Tirana.

Conclusion

Eni Bushi demonstrates a strong and evolving profile as a researcher, practitioner, and academic leader in the field of pharmaceutical sciences. Her combined background in pharmacy, business management, and pharmaceutical technology positions her uniquely to contribute to transformative change in drug formulation, health policy, and quality assurance. Her dedication to innovation, public health, and regulatory science makes her a highly deserving candidate for the Best Review Paper Award. Her work not only exemplifies academic excellence but also provides practical value to both the pharmaceutical industry and healthcare systems in Albania and beyond.